Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to Highly Active Antiretroviral Therapy (HAART) medication regimens among HIV-positive men and women

Dean G. Cruess, Sarah Minor, Michael H. Antoni, Theodore Millon

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to Highly Active Antiretroviral Therapy (HAART) medication regimens among HIV-positive men and women'. Together they form a unique fingerprint.

Medicine & Life Sciences